FindTrial
Sign In

To assess role of neutrophil count in abdominal fluid in patients with chronic liver disease for future development of infection in abdominal fluid and patientâ??s survival

Assessment of impact of ascitic fluid polymorphonuclear count on development of spontaneous bacterial peritonitis and survival in patients with liver cirrhosis and ascites

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035325
Enrollment
70
Registered
2021-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Control Intervention1: NIL: NIL

Sponsors

IGIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with liver cirrhosis and ascites

Exclusion criteria

Exclusion criteria: 1] Age 2.5 gram/dl 3] mixed ascites 4] secondary bacterial peritonitis 5] malignancy 6] Associated severe cardio respiratory disease 7] Pregnancy or lactation 8] HRS 9] Chronic kidney disease 10] Previous episodes of SBP 11] Refusal to give consent for participation in the study

Design outcomes

Primary

MeasureTime frame
1. Development of SBP 2. Survival at month 6 Timepoint: At 6 months—

Secondary

MeasureTime frame
1. Predictors of development of SBP and mortality 2. Development of acute kidney injury (Based on AKIN criteria) 3. Rehospitalisation 4. Number of paracentesis 5. Other complications like HE/Variceal bleeding / Hyponatraemia / Jaundice / sepsis Timepoint: At 6 months—

Countries

India

Contacts

Public ContactSanjeev Kumar Jha

Indira Gandhi Institute of Medical Sciences, Patna

drsanjeevjha2010@gmail.com09470835355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026